MRI for radiotherapy treatment planning of stage III NSCLC: an MRI optimization study in healthy volunteers and patients

niversity Medical Center Utrecht0 个研究点目标入组 30 人开始时间: 待定最近更新: 2024年6月11日

适应症

试验速览

暂无简介。

•Healthy volunteers:
•o≥18 years.
•oWritten informed consent.
•oPatients with histopathologically or cytologically proven stage III NSCLC (excluding T4N0) referred to the department of Radiation Oncology.
•o≥ 18 years.
•oWritten informed consent.
•oRecent (≤ 21 days) GFR value available

•Healthy volunteers:
•oVolunteers who meet exclusion criteria for MRI following the protocol of the departmentof Radiology of the UMC Utrecht.
•o Patients:
•oPatients who meet exclusion criteria for MRI following the protocol of the department of Radiology of the UMC Utrecht.
•oPatients for whom lying still in a supine position for 45 minutes is physically too strenuous (e.g. due to orthopnea).
•oGlomerular Filtration Rate (GFR) of <30 mL/min/1.73m2 (UMCU protocol ‘MRI Contra-indicaties’, Version 3 January 2013).
•oPatients with nephrogenic systemic fibrosis,nephrogenicfibrosingdermopathy or severe renal insufficiency (UMCU protocol ‘MRI Contra-indicaties’, Version 3 January 2013).

发起方